Introduction
Congestive heart failure (CHF) is recognized as one of the major risk factors for deep venous thrombosis (DVT) in the lower extremities [1] [2] [3] [4] and subsequent venous thromboembolism (VTE). The symptoms and signs of heart failure (HF), based on low cardiac output and elevated left and right ventricular (LV and RV) filling pressure, such as dyspnea on exertion, palpitation and leg edema, are usually more noticeable than VTE and commonly hinder its detection [3] . Vascular duplex scanning imaging, obtained with a highresolution probe, revealed that DVT was most commonly detected in deep small veins, especially the soleal vein [5, 6] . Although a reduced LV ejection fraction (LVEF) and stasis of venous flow in patients with CHF was thought to be the main reason for thrombogenesis in deep veins, the flow dynamics of lower extremity veins have not been fully evaluated. Intermittent pneumatic compression devices (IPC) have been used as an established method to prevent DVT in intensive care units. The effects of IPC on venous hemodynamics have been evaluated [7, 8] . Although the theoretical concern was that IPC might increase in venous return to the heart, a previous study demonstrated that the application of IPC did not alter any central hemodynamic parameters in CHF [9] . Impulse foot IPC (IF-IPC) and sequential foot and calf IPC (SFC-IPC) are widely used in a clinical setting, and some studies have investigated venous hemodynamics in the popliteal and common femoral veins in normal subjects [7] [8] [9] [10] . However, venous flow in the soleal vein has not been evaluated, particularly in patients with CHF. Furthermore, which type of IPC is more effective for increasing deep venous flow in CHF patients is still unknown. The present study was designed to evaluate the effects of IPC on the flow velocity of popliteal and soleal veins and to compare the efficacy of two different types of IPC in deep venous flow enhancement in patients with CHF.
Methods

Subjects
Venous flow was measured in the popliteal and soleal veins in 19 patients with CHF (9 male, 10 female; mean age 54.9 years) and 19 control subjects (9 male, 10 female; mean age 51.8 years). The enrolled CHF patients were admitted to our hospital for treatment of acute aggravation of HF. CHF was diagnosed by clinical manifestation, and physical and objective examinations based on LV systolic dysfunction, diastolic dysfunction, or both. Severity of CHF according to the New York Heart Association (NYHA) functional class was more than III. The central venous pressure in the CHF group was recorded with a central venous catheter. Inferior vena cava (IVC) collapsibility was also evaluated by ultrasonography as a marker of venous stasis [4] . Positive collapsibility was defined as respiratory change in IVC diameter of >50% [4] . The etiology of CHF in this cohort included ischemic heart disease, dilated cardiomyopathy, valvular disease, and dilated-phase hypertrophic cardiomyopathy (Table 1) . None of the control subjects had any history or clinical evidence of HF, venous dysfunction, VTE, DVT or other major risk factors for VTE.
Study design
The flow velocities of the popliteal and soleal veins were measured using a high-resolution linear probe (13 MHz) interfaced with an ultrasound unit (SSD␣-10, Aloka, Tokyo, Japan). A custom-made probe holder was used to hold the probe without excess compression on the deep veins throughout the study. The Doppler angle was maintained at less than 55
• . Soleal venous flow was measured from the posterior side of the leg with the subject in the prone position. The popliteal venous flow was obtained approximately 2 cm cephalad to the small saphenous vein junction with all subjects in the prone position. Venous flow velocities of the popliteal and soleal veins were measured in patients with CHF and control subjects: (1) at rest; (2) with SFC-IPC (Veno Stream 601-J, Terumo, Tokyo, Japan); and (3) with IF-IPC (AV impulse, Kobayashi Medical, Osaka, Japan) (Fig. 1) . The SFC-IPC consisted of an electrically driven air compressor and four air chambers that were inflated sequentially from the sole to the knee in approximately 10 s. The inflation started with a slow increase in pressure in each air chamber. This procedure was repeated every 60 s. The pneumatic compression pressure was adjusted to 50 mmHg. The IF-IPC consisted of a pneumatic impulse generator and a plastic inflatable foot pad. This system operated at an applied pressure of 130 mmHg, a deflation pressure of 0 mmHg, an inflation time of 1 s, and a frequency of 3 impulses per minute ( Fig. 1 ).
Statistical analysis
Values are expressed as mean ± standard deviation. The mean values were compared using the Student's t test for unpaired variables and Fisher's protected least significant difference test. Differences were considered significant if they exceeded the 95% confidence level (p < 0.05). All statistical calculations were conducted using Stat-View, version 5.0 (SAS Institute Inc., Cary, NC, USA).
The study protocol was approved by the Institutional Review Board at Yamaguchi University Hospital. Written informed consent was obtained from all participants prior to entering the study. 
Results
The LV end-diastolic diameter, RV-atrial pressure gradient, and diameter of the IVC were greater and LVEF was smaller in the CHF group compared with the control group. The mean central venous pressure in the CHF group was 11.8 ± 2.0 mmHg. The collapsibility of the IVC in CHF patients was markedly poorer than in control subjects (15.8% vs. 100%, p < 0.01) ( Table 1) .
Effects of IPC on venous flow
Representative changes of the venous flow waveform in popliteal (A) and soleal veins (B) in control subjects and in patients with CHF after applying the IPC at expiration are shown in Fig. 2 . With SFC-IPC, the venous flow velocity increased in the quad-phase with sequential inflation of the air chambers from the sole to the knee in both groups. With IF-IPC, the venous flow velocity rose rapidly and decreased within a short time.
Popliteal vein
In the resting condition, popliteal venous flow velocity in the CHF group was attenuated (12.8 ± 4.7 cm/s vs.
21.1 ± 13.5 cm/s; p < 0.05) (Fig. 3) . Application of SFC-IPC increased the peak and mean velocity of the popliteal vein in both control subjects and in patients with CHF. Although application of IF-IPC increased peak popliteal velocity compared with rest in both groups (Table 2) , the magnitude of the increased venous flow with IF-IPC was smaller than that with SFC-IPC (Table 2 ). Furthermore, augmentation of peak flow velocity with SFC-IPC in CHF patients was the same as in control subjects. However, the increase in peak flow velocity with IF-IPC in CHF patients was significantly lower than in control subjects (Fig. 3) .
Soleal vein
In the resting condition, there were no differences in the peak and mean velocity in the soleal veins between the CHF and control groups (peak: 4.3 ± 3.0 cm/s vs. 3.5 ± 1.8 cm/s; mean: 2.4 ± 1.9 cm/s vs. 2.0 ± 0.9 cm/s; both p = not significant [NS]). After applying SFC-IPC, the peak and mean velocity of the soleal vein in CHF patients increased to the same level as in the control group (peak: 77.9 ± 30.4 cm/s vs. 71.1 ± 19.9 cm/s; mean: 18.0 ± 7.7 cm/s vs. 19.8 ± 8.6 cm/s; both p = NS) (Fig. 4) . IF-IPC increased the peak soleal venous velocities com-
Figure 3
The peak velocities of the popliteal vein with or without intermittent pneumatic compression. Peak popliteal venous flow was attenuated in patients with CHF at rest. The SFC-IPC increased peak flow velocity of the popliteal vein in patients with CHF as well as in control subjects, but the increased velocity with IF-IPC in CHF patients was lower than that in control subjects. CHF, congestive heart failure; SFC-IPC, sequential foot and calf intermittent pneumatic compression device; IF-IPC, impulse foot intermittent pneumatic compression device.
pared to rest in control subjects, but not in CHF patients. The augmented peak flow velocity after applying IF-IPC was lower than that after applying SFC-IPC in both groups (Table 3 ).
Figure 4
The peak velocities of the soleal vein with or without intermittent pneumatic compression. There was no difference between peak soleal venous velocities in control subjects and in patients with CHF in the absence or presence of IPC devices. CHF, congestive heart failure; SFC-IPC, sequential foot and calf intermittent pneumatic compression device; IF-IPC, impulse foot intermittent pneumatic compression device.
Discussion
The present study illustrated the effect of different types of intermittent pneumatic compression devices on deep venous flow velocity in CHF patients. The most notable findings were as follows: (1) the peak flow velocity of the popliteal vein was attenuated in CHF patients; (2) after application of SFC-IPC and IF-IPC, peak popliteal venous flow velocities in control subjects and in CHF patients increased compared with those at rest; however, for IF-IPC, the increase in velocity in CHF patients was less than in control subjects; 
DVT in CHF
It was reported that the occurrence of DVT in the lower extremities was related to the severity of CHF [1] [2] [3] 11] , and that the risk of VTE increased as LVEF decreased: the odds ratio for VTE increased from 2.8 to 38.3 with a decrease in LVEF from 45 to 20% [1] , and the risk of DVT and VTE increased according to NYHA functional class [4, 12] . Furthermore, another study demonstrated that abnormal platelet function (levels of soluble P-selectin and von Willebrand factor) as well as high plasma viscosity contributed to a hypercoagulable state in CHF patients with more severe NYHA class [13] .
Deep venous flow velocities in patients with CHF
Many investigators have attempted to detect DVT by measuring the peak venous velocity in the superficial femoral vein using venous duplex ultrasound [7, 14] . Recently, advances in a high-resolution linear probe have revealed that DVT was most commonly detected in deep veins, particularly the soleal vein [5, 6] . Thus, we focused on the venous flow velocities in soleal as well as popliteal veins. This study revealed that popliteal venous flow velocity was lower in CHF patients than in control subjects. Venous flow velocity in lower extremity is affected by cardiac output, right atrial pressure, respiration, and calf contraction exercise [1, 15, 16] . The attenuation of popliteal venous flow velocity in CHF patients may be affected by increase in right atrial pressure. On the other hand, the soleal venous flow velocity even in control subjects was as low as the velocity in CHF patients in the resting condition (Table 3 ; Fig. 4 ). The soleal veins are peripheral veins and course beneath soleus muscle. Because soleal veins are small in diameter, these veins may be compressed by the muscle in lower limbs and the venous flow velocities may be low even in healthy subjects. In CHF patients, the reduction in cardiac output and elevated right atrial pressure may facilitate peripheral circulatory insufficiency in the lower extremities and may increase the risk of DVT. In contrast, because an increase in venous flow velocity with ankle and leg exercise in healthy subjects is expected [15, 16] , the incidence of DVT may be low in these subjects.
Effects of IPC on deep venous flow
IPC is recognized as a prophylactic device against DVT [7] [8] [9] [10] 17, 18] , and the guidelines for the prevention of VTE in 2008 recommended IPC as one of the most useful devices for prevention of VTE [19] . In this study, both SFC-IPC and IF-IPC augmented peak velocity in popliteal veins in control and CHF subjects. SFC-IPC also augmented the soleal venous velocity in both groups. On the other hand, IF-IPC slightly increased soleal venous velocity in control subjects but not in CHF patients. This different response to the two devices on soleal venous velocity may be accounted for by the anatomy of the plantar venous plexus and deep veins: the plantar venous plexus diverges into an outflow of one to four veins that flow into the posterior tibial venous system and into the popliteal vein [20] . The soleal vein also flows into the popliteal vein via the peroneal vein and not from the plantar venous plexus. A previous study reported that IF-IPC increased peak velocity in the posterior tibial veins but not in the anterior tibial and peroneal veins [20] . This report supported that IF-IPC might not increase venous flow in the soleal vein, which is not contiguous with the plantar venous plexus. The SFC-IPC compresses the lower extremity from the sole to the knee, increasing the velocity step-bystep with inflation of each air chamber. This device also may increase venous flow in the deep veins and provide sufficient improvements in venous clearance to help prevent venous hemostasis and thrombogenesis in CHF patients.
Study limitations
In this study, we did not evaluate changes in venous diameter while applying the IPC. Thus, we could not ascertain changes in the amount of venous flow before and during the application of IPC. Nevertheless, the radial shape of the vein is affected by venous pressure, the amount of venous return, and venous compression from surrounding tissues; therefore, evaluation of the venous diameter throughout the study may be unreliable. Our results suggested a prophylactic mechanism of IPC in thrombogenesis. However, we did not observe whether DVT was prevented by IPC in CHF patients. Further follow-up study is needed to confirm the prophylactic effects of these devices in CHF patients.
Conclusions
Two-dimensional Doppler scanning with a high-resolution linear probe revealed a significant increase in mean and peak velocities in the soleal and popliteal veins on application of SFC-IPC but not of IF-IPC in patients with CHF. These results indicate that SFC-IPC is likely to have a favorable effect in preventing DVT in patients with CHF.
